A Study of Trastuzumab in Combination With Capecitabine and Cisplatin in Patients With Tissue HER2- But Serum HER2+ AGC
Asan Medical Center
Asan Medical Center
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AstraZeneca
Leap Therapeutics, Inc.
Servicio de Salud Metropolitano Sur Oriente
Qilu Pharmaceutical Co., Ltd.
National Institutes of Health Clinical Center (CC)
Medical College of Wisconsin
Merck KGaA, Darmstadt, Germany
University of Campinas, Brazil
National Cancer Center, Korea
Institut Català d'Oncologia
H. Lee Moffitt Cancer Center and Research Institute
Duke University
Sixth Affiliated Hospital, Sun Yat-sen University
University of Turku